Trial Profile
Proposal for HPV Vaccination of Women in the City of Barretos. A Pioneering Project Designed by the Pio XII Foundation - Barretos Cancer Hospital
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Adverse reactions; Therapeutic Use
- 24 Jan 2012 Actual patient number is 1574 according to ClinicalTrials.gov.
- 24 Jan 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 24 Jan 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.